TY - JOUR AU - Jack, C. R. AU - Knopman, D. S. AU - Jagust, W. J. AU - Shaw, L. M. AU - Aisen, P. S. AU - Weiner, M. W. PY - 2010 DA - 2010// TI - Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade JO - Lancet Neurol VL - 9 UR - https://doi.org/10.1016/S1474-4422(09)70299-6 DO - 10.1016/S1474-4422(09)70299-6 ID - Jack2010 ER - TY - STD TI - Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, et al. Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):280-92. ID - ref2 ER - TY - JOUR AU - Dubois, B. AU - Feldman, H. H. AU - Jacova, C. AU - Cummings, J. L. AU - DeKosky, S. T. AU - Barberger-Gateau, P. PY - 2010 DA - 2010// TI - Revising the definition of Alzheimer’s disease: a new lexicon JO - Lancet Neurol VL - 9 UR - https://doi.org/10.1016/S1474-4422(10)70223-4 DO - 10.1016/S1474-4422(10)70223-4 ID - Dubois2010 ER - TY - JOUR AU - Dubois, B. AU - Feldman, H. H. AU - Jacova, C. AU - Hampel, H. AU - Molinuevo, J. L. AU - Blennow, K. PY - 2014 DA - 2014// TI - Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria JO - Lancet Neurol VL - 13 UR - https://doi.org/10.1016/S1474-4422(14)70090-0 DO - 10.1016/S1474-4422(14)70090-0 ID - Dubois2014 ER - TY - STD TI - Dubois B, Hampel H, Feldman HH, Scheltens P, Aisen P, Andrieu S, et al. Preclinical Alzheimer’s disease: definition, natural history, and diagnostic criteria. Alzheimers Dement. 2016;12(3):292-323. ID - ref5 ER - TY - STD TI - Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7(3):270–9. ID - ref6 ER - TY - JOUR AU - Albert, M. AU - Zhu, Y. AU - Moghekar, A. AU - Mori, S. AU - Miller, M. I. AU - Soldan, A. PY - 2018 DA - 2018// TI - Predicting progression from normal cognition to mild cognitive impairment for individuals at 5 years JO - Brain VL - 141 UR - https://doi.org/10.1093/brain/awx365 DO - 10.1093/brain/awx365 ID - Albert2018 ER - TY - JOUR AU - Clifford, R. J. J. AU - Knopman, D. S. AU - Jagust, W. J. AU - Petersen, R. C. AU - Weiner, M. W. AU - Aisen, P. S. PY - 2013 DA - 2013// TI - Update on hypothetical model of Alzheimer’s disease biomarkers JO - Lancet Neurol VL - 12 UR - https://doi.org/10.1016/S1474-4422(12)70291-0 DO - 10.1016/S1474-4422(12)70291-0 ID - Clifford2013 ER - TY - JOUR AU - Knopman, D. S. AU - Jack, C. R. AU - Wiste, H. J. AU - Weigand, S. D. AU - Vemuri, P. AU - Lowe, V. J. PY - 2013 DA - 2013// TI - Selective worsening of brain injury biomarker abnormalities in cognitively normal elderly persons with β-amyloidosis JO - JAMA Neurol. VL - 70 UR - https://doi.org/10.1001/jamaneurol.2013.182 DO - 10.1001/jamaneurol.2013.182 ID - Knopman2013 ER - TY - JOUR AU - Chételat, G. PY - 2013 DA - 2013// TI - Alzheimer disease: Aβ-independent processes-rethinking preclinical AD JO - Nat Rev Neurol VL - 9 UR - https://doi.org/10.1038/nrneurol.2013.21 DO - 10.1038/nrneurol.2013.21 ID - Chételat2013 ER - TY - JOUR AU - Edmonds, E. C. AU - Delano-Wood, L. AU - Galasko, D. R. AU - Salmon, D. P. AU - Bondi, M. W. PY - 2015 DA - 2015// TI - Subtle cognitive decline and biomarker staging in preclinical Alzheimer’s disease JO - J Alzheimers Dis VL - 47 UR - https://doi.org/10.3233/JAD-150128 DO - 10.3233/JAD-150128 ID - Edmonds2015 ER - TY - STD TI - Jack CR Jr, Knopman DS, Weigand SD, Wiste HJ, Vemuri P, Lowe V, et al. An operational approach to NIA-AA criteria for preclinical Alzheimer’s disease. Ann Neurol. 2013;71(6):765–75. ID - ref12 ER - TY - JOUR AU - Jack, C. R. AU - Hampel, H. J. AU - Universities, S. AU - Cu, M. AU - Petersen, R. C. PY - 2016 DA - 2016// TI - A new classification system for AD, independent of cognition A / T / N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers JO - Neurology VL - 0 ID - Jack2016 ER - TY - JOUR AU - Jack, C. R. AU - Bennett, D. A. AU - Blennow, K. AU - Carrillo, M. C. AU - Dunn, B. AU - Haeberlein, S. B. PY - 2018 DA - 2018// TI - NIA-AA Research Framework: toward a biological definition of Alzheimer’s disease JO - Alzheimers Dement VL - 14 UR - https://doi.org/10.1016/j.jalz.2018.02.018 DO - 10.1016/j.jalz.2018.02.018 ID - Jack2018 ER - TY - STD TI - Kern S, Zetterberg H, Kern J, Zettergren A, Waern M, Höglund K, et al. Prevalence of preclinical Alzheimer disease: Comparison of current classification systems. Neurology. 2018;90(19):e1682-91. ID - ref15 ER - TY - JOUR AU - Petersen, R. C. PY - 2004 DA - 2004// TI - Mild cognitive impairment as a clinical entity and treatment target JO - Arch Neurol VL - 62 UR - https://doi.org/10.1001/archneur.62.7.1160 DO - 10.1001/archneur.62.7.1160 ID - Petersen2004 ER - TY - JOUR AU - Winblad, B. AU - Palmer, K. AU - Kivipelto, M. AU - Jelic, V. AU - Fratiglioni, L. AU - Wahlund, L. -. O. PY - 2004 DA - 2004// TI - Mild cognitive impairment—beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment JO - J Intern Med VL - 256 UR - https://doi.org/10.1111/j.1365-2796.2004.01380.x DO - 10.1111/j.1365-2796.2004.01380.x ID - Winblad2004 ER - TY - JOUR AU - Storandt, M. AU - Grant, E. A. AU - Miller, J. P. AU - Morris, J. C. PY - 2006 DA - 2006// TI - Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI JO - Neurology VL - 67 UR - https://doi.org/10.1212/01.wnl.0000228231.26111.6e DO - 10.1212/01.wnl.0000228231.26111.6e ID - Storandt2006 ER - TY - JOUR AU - Duara, R. AU - Loewenstein, D. A. AU - Greig, M. T. AU - Potter, E. AU - Barker, W. AU - Raj, A. PY - 2011 DA - 2011// TI - Pre-MCI and MCI: neuropsychological, clinical, and imaging features and progression rates JO - Am J Geriatr Psychiatry VL - 19 UR - https://doi.org/10.1097/JGP.0b013e3182107c69 DO - 10.1097/JGP.0b013e3182107c69 ID - Duara2011 ER - TY - JOUR AU - Landau, S. M. AU - Mintun, M. A. AU - Joshi, A. D. AU - Koeppe, R. A. AU - Petersen, R. C. AU - Aisen, P. S. PY - 2012 DA - 2012// TI - Amyloid deposition, hypometabolism, and longitudinal cognitive decline JO - Ann Neurol VL - 72 UR - https://doi.org/10.1002/ana.23650 DO - 10.1002/ana.23650 ID - Landau2012 ER - TY - STD TI - Wu L, Rowley J, Mohades S, Leuzy A, Dauar MT, Shin M, et al. Dissociation between brain amyloid deposition and metabolism in early mild cognitive impairment. PLoS One. 2012;7(10):e47905. ID - ref21 ER - TY - JOUR AU - Qiu, Y. AU - Li, L. AU - Zhou, T. AU - Lu, W. PY - 2014 DA - 2014// TI - Alzheimer’s disease progression model based on integrated biomarkers and clinical measures JO - Acta Pharmacol Sin VL - 35 UR - https://doi.org/10.1038/aps.2014.57 DO - 10.1038/aps.2014.57 ID - Qiu2014 ER - TY - STD TI - Risacher SL, Kim S, Nho K, Shen L, Petersen RC, Jr CRJ, et al. APOE effect on Alzheimer's disease biomarkers in older adults with significant memory concern. Alzheimer’s Dement. 2015;11(12):1417-29. ID - ref23 ER - TY - JOUR AU - Epelbaum, S. AU - Genthon, R. AU - Cavedo, E. AU - Habert, M. O. AU - Lamari, F. AU - Gagliardi, G. PY - 2017 DA - 2017// TI - Preclinical Alzheimer’s disease: a systematic review of the cohorts underlying the concept JO - Alzheimers Dement VL - 13 UR - https://doi.org/10.1016/j.jalz.2016.12.003 DO - 10.1016/j.jalz.2016.12.003 ID - Epelbaum2017 ER - TY - JOUR AU - Insel, P. S. AU - Ossenkoppele, R. AU - Gessert, D. AU - Jagust, W. AU - Landau, S. AU - Hansson, O. PY - 2017 DA - 2017// TI - Time to amyloid positivity and preclinical changes in brain metabolism, atrophy, and cognition: evidence for emerging amyloid pathology in Alzheimer’s disease JO - Front Neurosci VL - 11 UR - https://doi.org/10.3389/fnins.2017.00281 DO - 10.3389/fnins.2017.00281 ID - Insel2017 ER - TY - JOUR AU - Soldan, A. AU - Pettigrew, C. AU - Cai, Q. AU - Wang, M. C. AU - Moghekar, A. R. AU - O’Brien, R. J. PY - 2016 DA - 2016// TI - Hypothetical preclinical Alzheimer disease groups and longitudinal cognitive change JO - JAMA Neurol. VL - 73 UR - https://doi.org/10.1001/jamaneurol.2016.0194 DO - 10.1001/jamaneurol.2016.0194 ID - Soldan2016 ER - TY - STD TI - Rentz DM, Parra Rodriguez MA, Amariglio R, Stern Y, Sperling R, Ferris S. Promising developments in neuropsychological approaches for the detection of preclinical Alzheimer’s disease: a selective review. Alzheimers Res Ther. 2013;5(6):58. ID - ref27 ER - TY - JOUR AU - Papp, K. V. AU - Rentz, D. M. AU - Orlovsky, I. AU - Sperling, R. A. AU - Mormino, E. C. PY - 2017 DA - 2017// TI - Optimizing the preclinical Alzheimer’s cognitive composite with semantic processing: The PACC5 JO - Alzheimer’s Dement Transl Res Clin Interv VL - 3 UR - https://doi.org/10.1016/j.trci.2017.10.004 DO - 10.1016/j.trci.2017.10.004 ID - Papp2017 ER - TY - JOUR AU - Mormino, E. C. AU - Papp, K. V. AU - Rentz, D. M. AU - Donohue, M. C. AU - Amariglio, R. AU - Quiroz, Y. T. PY - 2017 DA - 2017// TI - Early and late change on the preclinical Alzheimer’s cognitive composite in clinically normal older individuals with elevated amyloid β JO - Alzheimers Dement VL - 13 UR - https://doi.org/10.1016/j.jalz.2017.01.018 DO - 10.1016/j.jalz.2017.01.018 ID - Mormino2017 ER - TY - JOUR AU - Buckley, R. F. AU - Maruff, P. AU - Ames, D. AU - Bourgeat, P. AU - Martins, R. N. AU - Masters, C. L. PY - 2016 DA - 2016// TI - Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer’s disease JO - Alzheimers Dement VL - 12 UR - https://doi.org/10.1016/j.jalz.2015.12.013 DO - 10.1016/j.jalz.2015.12.013 ID - Buckley2016 ER - TY - JOUR AU - Lim, Y. Y. AU - Snyder, P. J. AU - Pietrzak, R. H. AU - Ukiqi, A. AU - Villemagne, V. L. AU - Ames, D. PY - 2016 DA - 2016// TI - Sensitivity of composite scores to amyloid burden in preclinical Alzheimer’s disease: introducing the Z-scores of Attention, Verbal fluency, and Episodic memory for Nondemented older adults composite score JO - Alzheimer’s Dement Diagn Assess Dis Monit. VL - 2 ID - Lim2016 ER - TY - JOUR AU - Langbaum, J. B. AU - Hendrix, S. B. AU - Ayutyanont, N. AU - Chen, K. AU - Fleisher, A. S. AU - Shah, R. C. PY - 2014 DA - 2014// TI - An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer’s disease JO - Alzheimers Dement VL - 10 UR - https://doi.org/10.1016/j.jalz.2014.02.002 DO - 10.1016/j.jalz.2014.02.002 ID - Langbaum2014 ER - TY - JOUR AU - Amariglio, R. E. AU - Becker, J. A. AU - Carmasin, J. AU - Wadsworth, L. P. AU - Lorius, N. AU - Sullivan, C. PY - 2012 DA - 2012// TI - Subjective cognitive complaints and amyloid burden in cognitively normal older individuals JO - Neuropsychologia VL - 50 UR - https://doi.org/10.1016/j.neuropsychologia.2012.08.011 DO - 10.1016/j.neuropsychologia.2012.08.011 ID - Amariglio2012 ER - TY - JOUR AU - Amariglio, R. E. AU - Donohue, M. C. AU - Marshall, G. A. AU - Rentz, D. M. AU - Salmon, D. P. AU - Ferris, S. H. PY - 2015 DA - 2015// TI - Tracking early decline in cognitive function in older individuals at risk for Alzheimer’s disease dementia: the Alzheimer’s Disease Cooperative Study Cognitive Function Instrument HHS Public Access JO - JAMA Neurol VL - 72 UR - https://doi.org/10.1001/jamaneurol.2014.3375 DO - 10.1001/jamaneurol.2014.3375 ID - Amariglio2015 ER - TY - JOUR AU - Reisberg, B. AU - Prichep, L. AU - Mosconi, L. AU - John, E. R. AU - Glodzik-Sobanska, L. AU - Boksay, I. PY - 2008 DA - 2008// TI - The pre-mild cognitive impairment, subjective cognitive impairment stage of Alzheimer’s disease JO - Alzheimer’s Dement VL - 4 UR - https://doi.org/10.1016/j.jalz.2007.11.017 DO - 10.1016/j.jalz.2007.11.017 ID - Reisberg2008 ER - TY - JOUR AU - Harten, A. C. AU - Visser, P. J. AU - Pijnenburg, Y. A. L. AU - Teunissen, C. E. AU - Blankenstein, M. A. AU - Scheltens, P. PY - 2013 DA - 2013// TI - Cerebrospinal fluid Aβ42 is the best predictor of clinical progression in patients with subjective complaints JO - Alzheimers Dement VL - 9 UR - https://doi.org/10.1016/j.jalz.2012.08.004 DO - 10.1016/j.jalz.2012.08.004 ID - Harten2013 ER - TY - JOUR AU - Stewart, R. AU - Godin, O. AU - Crivello, F. AU - Maillard, P. AU - Mazoyer, B. AU - Tzourio, C. PY - 2011 DA - 2011// TI - Longitudinal neuroimaging correlates of subjective memory impairment: 4-year prospective community study JO - Br J Psychiatry VL - 198 UR - https://doi.org/10.1192/bjp.bp.110.078683 DO - 10.1192/bjp.bp.110.078683 ID - Stewart2011 ER - TY - JOUR AU - Abdulrab, K. AU - Heun, R. PY - 2008 DA - 2008// TI - Subjective memory impairment. A review of its definitions indicates the need for a comprehensive set of standardised and validated criteria JO - Eur Psychiatry VL - 23 UR - https://doi.org/10.1016/j.eurpsy.2008.02.004 DO - 10.1016/j.eurpsy.2008.02.004 ID - Abdulrab2008 ER - TY - STD TI - Jessen F, Amariglio RE, Van Boxtel M, Breteler M, Ceccaldi M, Chételat G, et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer’s disease. Alzheimers Dement. 2014;10(6):844-52. ID - ref39 ER - TY - JOUR AU - Mitchell, A. J. AU - Beaumont, H. AU - Ferguson, D. AU - Yadegarfar, M. AU - Stubbs, B. PY - 2014 DA - 2014// TI - Risk of dementia and mild cognitive impairment in older people with subjective memory complaints: meta-analysis JO - Acta Psychiatr Scand VL - 130 UR - https://doi.org/10.1111/acps.12336 DO - 10.1111/acps.12336 ID - Mitchell2014 ER - TY - JOUR AU - Ferreira, D. AU - Falahati, F. AU - Linden, C. AU - Buckley, R. F. AU - Ellis, K. A. AU - Savage, G. PY - 2017 DA - 2017// TI - A “Disease Severity Index” to identify individuals with subjective memory decline who will progress to mild cognitive impairment or dementia JO - Sci Rep VL - 7 ID - Ferreira2017 ER - TY - JOUR AU - Amariglio, R. E. AU - Mormino, E. C. AU - Pietras, A. C. AU - Marshall, G. A. AU - Vannini, P. AU - Johnson, K. A. PY - 2015 DA - 2015// TI - Subjective cognitive concerns, amyloid-β, and neurodegeneration in clinically normal elderly JO - Neurology VL - 85 UR - https://doi.org/10.1212/WNL.0000000000001712 DO - 10.1212/WNL.0000000000001712 ID - Amariglio2015 ER - TY - JOUR AU - Rabin, L. A. AU - Smart, C. M. AU - Crane, P. K. AU - Amariglio, R. E. AU - Berman, L. M. AU - Boada, M. PY - 2015 DA - 2015// TI - Subjective cognitive decline in older adults: an overview of self-report measures used across 19 international research studies JO - J Alzheimers Dis VL - 48 UR - https://doi.org/10.3233/JAD-150154 DO - 10.3233/JAD-150154 ID - Rabin2015 ER - TY - STD TI - Gallassi R, Oppi F, Poda R, Scortichini S, Maserati MS, Marano G, et al. Are subjective cognitive complaints a risk factor for dementia. Neurol Sci. 2010;31(3):327-36. ID - ref44 ER - TY - STD TI - van Oijen M, de Jong FJ, Hofman A, Koudstaal PJ, Breteler MMB. Subjective memory complaints, education, and risk of Alzheimer’s disease. Alzheimers Dement. 2007;3(2):92-7. ID - ref45 ER - TY - JOUR AU - Molinuevo, J. L. AU - Rabin, L. A. AU - Amariglio, R. AU - Buckley, R. AU - Dubois, B. AU - Ellis, K. A. PY - 2017 DA - 2017// TI - Implementation of subjective cognitive decline criteria in research studies JO - Alzheimers Dement VL - 13 UR - https://doi.org/10.1016/j.jalz.2016.09.012 DO - 10.1016/j.jalz.2016.09.012 ID - Molinuevo2017 ER - TY - JOUR AU - Koppara, A. AU - Wagner, M. AU - Lange, C. AU - Ernst, A. AU - Wiese, B. AU - König, H. H. PY - 2015 DA - 2015// TI - Cognitive performance before and after the onset of subjective cognitivedecline in old age JO - Alzheimer’s Dement Diagn Assess Dis Monit VL - 1 ID - Koppara2015 ER - TY - JOUR AU - Jessen, F. AU - Wiese, B. AU - Bachmann, C. AU - Eifflaender-Gorfer, S. PY - 2010 DA - 2010// TI - Prediction of dementia by subjective memory impairment JO - Arch Gen Psychiatry VL - 67 UR - https://doi.org/10.1001/archgenpsychiatry.2010.30 DO - 10.1001/archgenpsychiatry.2010.30 ID - Jessen2010 ER - TY - JOUR AU - Dubois, B. PY - 2018 DA - 2018// TI - The emergence of a new conceptual framework for Alzheimer’s disease JO - J Alzheimers Dis VL - 62 UR - https://doi.org/10.3233/JAD-170536 DO - 10.3233/JAD-170536 ID - Dubois2018 ER - TY - JOUR AU - Pike, K. E. AU - Ellis, K. A. AU - Villemagne, V. L. AU - Good, N. AU - Chételat, G. AU - Ames, D. PY - 2011 DA - 2011// TI - Cognition and beta-amyloid in preclinical Alzheimer’s disease: data from the AIBL study JO - Neuropsychologia VL - 49 UR - https://doi.org/10.1016/j.neuropsychologia.2011.04.012 DO - 10.1016/j.neuropsychologia.2011.04.012 ID - Pike2011 ER - TY - JOUR AU - Hollands, S. AU - Lim, Y. Y. AU - Buckley, R. AU - Pietrzak, R. H. AU - Snyder, P. J. AU - Ames, D. PY - 2015 DA - 2015// TI - Amyloid-β related memory decline is not associated with subjective or informant rated cognitive impairment in healthy adults JO - J Alzheimers Dis VL - 43 UR - https://doi.org/10.3233/JAD-140678 DO - 10.3233/JAD-140678 ID - Hollands2015 ER - TY - STD TI - Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100. ID - ref52 ER - TY - JOUR AU - Dubois, B. AU - Feldman, H. H. AU - Jacova, C. AU - DeKosky, S. T. AU - Barberger-Gateau, P. AU - Cummings, J. PY - 2007 DA - 2007// TI - Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria JO - Lancet Neurol VL - 6 UR - https://doi.org/10.1016/S1474-4422(07)70178-3 DO - 10.1016/S1474-4422(07)70178-3 ID - Dubois2007 ER - TY - JOUR AU - Hoy, D. AU - Brooks, P. AU - Woolf, A. AU - Blyth, F. AU - March, L. AU - Bain, C. PY - 2012 DA - 2012// TI - Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement JO - J Clin Epidemiol VL - 65 UR - https://doi.org/10.1016/j.jclinepi.2011.11.014 DO - 10.1016/j.jclinepi.2011.11.014 ID - Hoy2012 ER - TY - STD TI - Schwarzer G, Carpenter JR, Rücker G. Fixed effect and random effects meta-analysis. In: Meta-Analysis with R. Cham: Springer; 2015. p. 21-53. ID - ref55 ER - TY - JOUR AU - Dubois, B. AU - Epelbaum, S. AU - Nyasse, F. AU - Bakardjian, H. AU - Gagliardi, G. AU - Uspenskaya, O. PY - 2018 DA - 2018// TI - Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer’s disease (INSIGHT-preAD): a longitudinal observational study JO - Lancet Neurol VL - 17 UR - https://doi.org/10.1016/S1474-4422(18)30029-2 DO - 10.1016/S1474-4422(18)30029-2 ID - Dubois2018 ER - TY - JOUR AU - Zhao, Y. AU - Tudorascu, D. L. AU - Lopez, O. L. AU - Cohen, A. D. AU - Mathis, C. A. AU - Aizenstein, H. J. PY - 2018 DA - 2018// TI - Amyloid β deposition and suspected non-Alzheimer pathophysiology and cognitive decline patterns for 12 years in oldest old participants without dementia JO - JAMA Neurol. VL - 75 UR - https://doi.org/10.1001/jamaneurol.2017.3029 DO - 10.1001/jamaneurol.2017.3029 ID - Zhao2018 ER - TY - JOUR AU - Mandecka, M. AU - Budziszewska, M. AU - Barczak, A. AU - Pepłońska, B. AU - Chodakowska-Żebrowska, M. AU - Filipek-Gliszczyńska, A. PY - 2016 DA - 2016// TI - Association between cerebrospinal fluid biomarkers for Alzheimer’s disease, APOE genotypes and auditory verbal learning task in subjective cognitive decline, mild cognitive impairment, and Alzheimer’s disease JO - J Alzheimers Dis VL - 54 UR - https://doi.org/10.3233/JAD-160176 DO - 10.3233/JAD-160176 ID - Mandecka2016 ER - TY - JOUR AU - Visser, P. J. AU - Verhey, F. AU - Knol, D. L. AU - Scheltens, P. AU - Wahlund, L. O. AU - Freund-Levi, Y. PY - 2009 DA - 2009// TI - Prevalence and prognostic value of CSF markers of Alzheimer’s disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study JO - Lancet Neurol VL - 8 UR - https://doi.org/10.1016/S1474-4422(09)70139-5 DO - 10.1016/S1474-4422(09)70139-5 ID - Visser2009 ER - TY - JOUR AU - Vos, S. J. B. AU - Verhey, F. AU - Frölich, L. AU - Kornhuber, J. AU - Wiltfang, J. AU - Maier, W. PY - 2015 DA - 2015// TI - Prevalence and prognosis of Alzheimer’s disease at the mild cognitive impairment stage JO - Brain VL - 138 UR - https://doi.org/10.1093/brain/awv029 DO - 10.1093/brain/awv029 ID - Vos2015 ER - TY - JOUR AU - Palmqvist, S. AU - Zetterberg, H. AU - Mattsson, N. AU - Johansson, P. AU - Minthon, L. AU - Blennow, K. PY - 2015 DA - 2015// TI - Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease JO - Neurology VL - 85 UR - https://doi.org/10.1212/WNL.0000000000001991 DO - 10.1212/WNL.0000000000001991 ID - Palmqvist2015 ER - TY - JOUR AU - Vos, S. J. B. AU - Xiong, C. AU - Visser, P. J. AU - Jasielec, M. S. AU - Hassenstab, J. AU - Grant, E. A. PY - 2013 DA - 2013// TI - Preclinical Alzheimer’s disease and its outcome: a longitudinal cohort study JO - Lancet Neurol VL - 12 UR - https://doi.org/10.1016/S1474-4422(13)70194-7 DO - 10.1016/S1474-4422(13)70194-7 ID - Vos2013 ER - TY - STD TI - Vos SJB, Visser PJ. Preclinical Alzheimer’s disease: implications for refinement of the concept. J Alzheimer’s Dis. 2018;64:S213–27. ID - ref63 ER - TY - STD TI - Mattsson N, Insel PS, Donohue M, Landau S, Jagust WJ, Shaw LM, et al. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer’s disease. Brain. 2014;138(3):772-83. ID - ref64 ER - TY - JOUR AU - Jansen, W. J. AU - Ossenkoppele, R. AU - Knol, D. L. AU - Tijms, B. M. AU - Scheltens, P. AU - Verhey, F. R. J. PY - 2015 DA - 2015// TI - Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis JO - JAMA VL - 313 UR - https://doi.org/10.1001/jama.2015.4668 DO - 10.1001/jama.2015.4668 ID - Jansen2015 ER - TY - JOUR AU - Mattsson, N. AU - Rich, K. AU - Kaiser, E. AU - Rikkert, M. PY - 2012 DA - 2012// TI - Age and diagnostic performance of Alzheimer disease CFS biomarkers JO - Neurology VL - 78 UR - https://doi.org/10.1212/WNL.0b013e3182477eed DO - 10.1212/WNL.0b013e3182477eed ID - Mattsson2012 ER - TY - JOUR AU - Jack, C. R. AU - Therneau, T. M. AU - Wiste, H. J. AU - Weigand, S. D. AU - Knopman, D. S. AU - Lowe, V. J. PY - 2016 DA - 2016// TI - Transition rates between amyloid and neurodegeneration biomarker states and to dementia: a population-based, longitudinal cohort study JO - Lancet Neurol VL - 15 UR - https://doi.org/10.1016/S1474-4422(15)00323-3 DO - 10.1016/S1474-4422(15)00323-3 ID - Jack2016 ER - TY - JOUR AU - Gordon, B. A. AU - Najmi, S. AU - Hsu, P. AU - Roe, C. M. AU - Morris, J. C. AU - Benzinger, T. L. S. PY - 2015 DA - 2015// TI - The effects of white matter hyperintensities and amyloid deposition on Alzheimer dementia JO - NeuroImage Clin VL - 8 UR - https://doi.org/10.1016/j.nicl.2015.04.017 DO - 10.1016/j.nicl.2015.04.017 ID - Gordon2015 ER - TY - JOUR AU - Arenaza-Urquijo, E. M. AU - Bejanin, A. AU - Gonneaud, J. AU - Wirth, M. AU - Joie, R. AU - Mutlu, J. PY - 2017 DA - 2017// TI - Association between educational attainment and amyloid deposition across the spectrum from normal cognition to dementia: neuroimaging evidence for protection and compensation JO - Neurobiol Aging VL - 59 UR - https://doi.org/10.1016/j.neurobiolaging.2017.06.016 DO - 10.1016/j.neurobiolaging.2017.06.016 ID - Arenaza-Urquijo2017 ER - TY - JOUR AU - Snyder, P. J. AU - Johnson, L. N. AU - Lim, Y. Y. AU - Santos, C. Y. AU - Alber, J. AU - Maruff, P. PY - 2016 DA - 2016// TI - Nonvascular retinal imaging markers of preclinical Alzheimer’s disease JO - Alzheimer’s Dement Diagn Assess Dis Monit. VL - 4 ID - Snyder2016 ER - TY - JOUR AU - Vassilaki, M. AU - Aakre, J. A. AU - Mielke, M. M. AU - Geda, Y. E. AU - Kremers, W. K. AU - Alhurani, R. E. PY - 2016 DA - 2016// TI - Multimorbidity and neuroimaging biomarkers among cognitively normal persons JO - Neurology VL - 86 UR - https://doi.org/10.1212/WNL.0000000000002624 DO - 10.1212/WNL.0000000000002624 ID - Vassilaki2016 ER - TY - JOUR AU - Eckerström, M. AU - Göthlin, M. AU - Rolstad, S. AU - Hessen, E. AU - Eckerström, C. AU - Nordlund, A. PY - 2017 DA - 2017// TI - Longitudinal evaluation of criteria for subjective cognitive decline and preclinical Alzheimer’s disease in a memory clinic sample JO - Alzheimer’s Dement Diagn Assess Dis Monit. VL - 8 ID - Eckerström2017 ER - TY - JOUR AU - Knopman, D. S. AU - Jack, C. R. AU - Wiste, H. J. AU - Weigand, S. D. AU - Vemuri, P. AU - Lowe, V. PY - 2012 DA - 2012// TI - Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease JO - Neurology VL - 78 UR - https://doi.org/10.1212/WNL.0b013e3182563bbe DO - 10.1212/WNL.0b013e3182563bbe ID - Knopman2012 ER - TY - JOUR AU - Perrotin, A. AU - Joie, R. AU - Sayette, V. AU - Barré, L. AU - Mézenge, F. AU - Mutlu, J. PY - 2017 DA - 2017// TI - Subjective cognitive decline in cognitively normal elders from the community or from a memory clinic: differential affective and imaging correlates JO - Alzheimers Dement VL - 13 UR - https://doi.org/10.1016/j.jalz.2016.08.011 DO - 10.1016/j.jalz.2016.08.011 ID - Perrotin2017 ER - TY - JOUR AU - Stenset, V. AU - Hofoss, D. AU - Johnsen, L. AU - Skinningsrud, A. AU - Berstad, A. E. AU - Negaard, A. PY - 2008 DA - 2008// TI - White matter lesion severity is associated with reduced cognitive performances in patients with normal CSF Aβ42 levels JO - Acta Neurol Scand VL - 118 UR - https://doi.org/10.1111/j.1600-0404.2008.01045.x DO - 10.1111/j.1600-0404.2008.01045.x ID - Stenset2008 ER - TY - BOOK AU - Opdebeeck, C. AU - Yates, J. A. AU - Kudlicka, A. AU - Martyr, A. PY - 2018 DA - 2018// TI - What are subjective cognitive difficulties and do they matter? Age Ageing ID - Opdebeeck2018 ER - TY - JOUR AU - Barthel, H. AU - Gertz, H. J. AU - Dresel, S. AU - Peters, O. AU - Bartenstein, P. AU - Buerger, K. PY - 2011 DA - 2011// TI - Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer’s disease and healthy controls: a multicentre phase 2 diagnostic study JO - Lancet Neurol VL - 10 UR - https://doi.org/10.1016/S1474-4422(11)70077-1 DO - 10.1016/S1474-4422(11)70077-1 ID - Barthel2011 ER - TY - JOUR AU - Besson, F. L. AU - Joie, R. AU - Doeuvre, L. AU - Gaubert, M. AU - Mezenge, F. AU - Egret, S. PY - 2015 DA - 2015// TI - Cognitive and brain profiles associated with current neuroimaging biomarkers of preclinical Alzheimer’s disease JO - J Neurosci VL - 35 UR - https://doi.org/10.1523/JNEUROSCI.0150-15.2015 DO - 10.1523/JNEUROSCI.0150-15.2015 ID - Besson2015 ER - TY - JOUR AU - Brier, M. R. AU - McCarthy, J. E. AU - Benzinger, T. L. S. AU - Stern, A. AU - Su, Y. AU - Friedrichsen, K. A. PY - 2016 DA - 2016// TI - Local and distributed PiB accumulation associated with development of preclinical Alzheimer’s disease JO - Neurobiol Aging VL - 38 UR - https://doi.org/10.1016/j.neurobiolaging.2015.10.025 DO - 10.1016/j.neurobiolaging.2015.10.025 ID - Brier2016 ER - TY - JOUR AU - Byun, M. S. AU - Yi, D. AU - Lee, D. Y. AU - Kim, H. J. AU - Choi, H. J. AU - Lee, J. Y. PY - 2017 DA - 2017// TI - Differential effects of blood insulin and HbA1c on cerebral amyloid burden and neurodegeneration in nondiabetic cognitively normal older adults JO - Neurobiol Aging VL - 59 UR - https://doi.org/10.1016/j.neurobiolaging.2017.07.004 DO - 10.1016/j.neurobiolaging.2017.07.004 ID - Byun2017 ER - TY - JOUR AU - Cho, H. AU - Choi, J. Y. AU - Hwang, M. S. AU - Kim, Y. J. AU - Lee, H. M. AU - Lee, H. S. PY - 2016 DA - 2016// TI - In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum JO - Ann Neurol VL - 80 UR - https://doi.org/10.1002/ana.24711 DO - 10.1002/ana.24711 ID - Cho2016 ER - TY - JOUR AU - Clark, L. R. AU - Berman, S. E. AU - Norton, D. AU - Koscik, R. L. AU - Jonaitis, E. AU - Blennow, K. PY - 2018 DA - 2018// TI - Age-accelerated cognitive decline in asymptomatic adults with CSF β-amyloid JO - Neurology VL - 90 UR - https://doi.org/10.1212/WNL.0000000000005291 DO - 10.1212/WNL.0000000000005291 ID - Clark2018 ER - TY - STD TI - Harrington MG, Chiang J, Pogoda JM, Gomez M, Thomas K, Marion SDB, et al. Executive function changes before memory in preclinical Alzheimer’s pathology: a prospective, cross-sectional, case control study. PLoS One. 2013;8(11):e79378. ID - ref83 ER - TY - JOUR AU - Hatashita, S. AU - Yamasaki, H. PY - 2010 DA - 2010// TI - Clinically different stages of Alzheimer’s disease associated by amyloid deposition with [11C]-PIB PET imaging JO - J Alzheimers Dis VL - 21 UR - https://doi.org/10.3233/JAD-2010-100222 DO - 10.3233/JAD-2010-100222 ID - Hatashita2010 ER - TY - STD TI - Johnson KA, Sperling RA, Gidicsin C, Carmasin J, Maye J, Coleman RE, Reiman EM, Sabbagh MN, Sadowsky CH, Fleisher AS, Doraiswamy PM, Carpenter AP, Clark CM, Joshi AD, Lu M, Grundman M, Mintun MA, Pontecorvo MJ, Skovronsky DA-A study group. Florbetapir (F18-AV-450 PET to assess amyloid burden in Alzheimer’s disease dementia, mild cognitive impairment, and normal aging. Alzheimers Dement. 2013;9(5):S72-83. ID - ref85 ER - TY - JOUR AU - Lilamand, M. AU - Cesari, M. AU - Campo, N. AU - Cantet, C. AU - Soto, M. AU - Ousset, P. -. J. PY - 2016 DA - 2016// TI - Brain amyloid deposition is associated with lower instrumental activities of daily living abilities in older adults. Results from the MAPT Study JO - J Gerontol Ser A Biol Sci Med Sci VL - 71 UR - https://doi.org/10.1093/gerona/glv155 DO - 10.1093/gerona/glv155 ID - Lilamand2016 ER - TY - JOUR AU - Lim, H. K. AU - Nebes, R. AU - Snitz, B. AU - Cohen, A. AU - Mathis, C. AU - Price, J. PY - 2014 DA - 2014// TI - Regional amyloid burden and intrinsic connectivity networks in cognitively normal elderly subjects JO - Brain VL - 137 UR - https://doi.org/10.1093/brain/awu271 DO - 10.1093/brain/awu271 ID - Lim2014 ER - TY - JOUR AU - Meyer, P. F. AU - Savard, M. AU - Poirier, J. AU - Labonté, A. AU - Rosa-Neto, P. AU - Weitz, T. M. PY - 2018 DA - 2018// TI - Bi-directional association of cerebrospinal fluid immune markers with stage of Alzheimer’s disease pathogenesis JO - J Alzheimers Dis VL - 63 UR - https://doi.org/10.3233/JAD-170887 DO - 10.3233/JAD-170887 ID - Meyer2018 ER - TY - JOUR AU - Montal, V. AU - Vilaplana, E. AU - Alcolea, D. AU - Pegueroles, J. AU - Pasternak, O. AU - González-Ortiz, S. PY - 2018 DA - 2018// TI - Cortical microstructural changes along the Alzheimer’s disease continuum JO - Alzheimers Dement VL - 14 UR - https://doi.org/10.1016/j.jalz.2017.09.013 DO - 10.1016/j.jalz.2017.09.013 ID - Montal2018 ER - TY - JOUR AU - Ossenkoppele, R. AU - Madison, C. AU - Oh, H. AU - Wirth, M. AU - Berckel, B. N. M. AU - Jagust, W. J. PY - 2014 DA - 2014// TI - Is verbal episodic memory in elderly with amyloid deposits preserved through altered neuronal function? JO - Cereb Cortex VL - 24 UR - https://doi.org/10.1093/cercor/bht076 DO - 10.1093/cercor/bht076 ID - Ossenkoppele2014 ER - TY - JOUR AU - Rodrigue, K. M. AU - Kennedy, K. M. AU - Devous, M. D. AU - Rieck, J. R. AU - Hebrank, A. C. AU - Diaz-Arrastia, R. PY - 2012 DA - 2012// TI - β-amyloid burden in healthy aging: regional distribution and cognitive consequences JO - Neurology VL - 78 UR - https://doi.org/10.1212/WNL.0b013e318245d295 DO - 10.1212/WNL.0b013e318245d295 ID - Rodrigue2012 ER - TY - STD TI - Schoonenboom NSM, Reesink FE, Verwey NA, Kester MI, Teunissen CE, Van De Ven PM, et al. Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort. Neurology. 2012;78(1):47–54. ID - ref92 ER - TY - STD TI - Taylor MK, Sullivan DK, Swerdlow RH, Vidoni ED, Morris JK, Mahnken JD, et al. A high-glycemic diet is associated with cerebral amyloid burden in cognitively normal older adults. The American journal of clinical nutrition. 2017;106(6):1463-70. ID - ref93 ER - TY - JOUR AU - Um, Y. H. AU - Choi, W. H. AU - Jung, W. S. AU - Park, Y. H. AU - Lee, C. U. AU - Lim, H. K. PY - 2017 DA - 2017// TI - Whole brain voxel-wise analysis of cerebral retention of beta-amyloid in cognitively normal older adults using18F-florbetaben JO - Psychiatry Investig VL - 14 UR - https://doi.org/10.4306/pi.2017.14.6.883 DO - 10.4306/pi.2017.14.6.883 ID - Um2017 ER - TY - JOUR AU - Harten, A. C. AU - Smits, L. L. AU - Teunissen, C. E. AU - Visser, P. J. AU - Koene, T. AU - Blankenstein, M. A. PY - 2013 DA - 2013// TI - Preclinical AD predicts decline in memory and executive functions in subjective complaints JO - Neurology VL - 81 UR - https://doi.org/10.1212/WNL.0b013e3182a8418b DO - 10.1212/WNL.0b013e3182a8418b ID - Harten2013 ER - TY - JOUR AU - Wolfsgruber, S. AU - Polcher, A. AU - Koppara, A. AU - Kleineidam, L. AU - Frölich, L. AU - Peters, O. PY - 2017 DA - 2017// TI - Cerebrospinal fluid biomarkers and clinical progression in patients with subjective cognitive decline and mild cognitive impairment JO - J Alzheimers Dis VL - 58 UR - https://doi.org/10.3233/JAD-161252 DO - 10.3233/JAD-161252 ID - Wolfsgruber2017 ER -